Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage

NCT ID: NCT06342375

Last Updated: 2025-12-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

425000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-12

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to try new outreach methods to improve access to Medicaid for those who lost Medicaid for procedural reasons. The main questions it aims to answer are:

1. How does a live phone call from a Navigator impact Medicaid enrollment among people who lost Medicaid coverage for procedural reasons?
2. What is the effectiveness of outreach using a live call rather than a pre-recorded call?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

No Medicaid Coverage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Live Outreach

People in this cohort will receive a live outbound call from a Navigator

Group Type EXPERIMENTAL

Outbound phone call

Intervention Type OTHER

Participants will receive either a live or pre-recorded outbound phone call

Pre-recorded Outreach

People in this cohort will receive a pre-recorded outbound call providing a hotline number

Group Type EXPERIMENTAL

Outbound phone call

Intervention Type OTHER

Participants will receive either a live or pre-recorded outbound phone call

No outreach

People in this cohort will not receive outreach of any kind

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Outbound phone call

Participants will receive either a live or pre-recorded outbound phone call

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Eligible for Medicaid
* Lost Medicaid coverage between June 2024 and November 2025

Exclusion Criteria

* Preferring a language other than English, Spanish, or Hmong
* No working phone number
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Covering Wisconsin

UNKNOWN

Sponsor Role collaborator

Arnold Ventures

UNKNOWN

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rebecca Myerson, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Wisconsin - Madison

Madison, Wisconsin, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rebecca Myerson, PhD

Role: CONTACT

608-263-2082

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rebecca Myerson, PhD

Role: primary

608-263-2082

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A538500

Identifier Type: OTHER

Identifier Source: secondary_id

Protocol Version 4/17/2025

Identifier Type: OTHER

Identifier Source: secondary_id

SMPH/POP HEALTH SCI/POP HLTH

Identifier Type: OTHER

Identifier Source: secondary_id

2024-0434

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Remote Presence Timely Discharge Management
NCT00364117 WITHDRAWN PHASE2/PHASE3